• Generic name: Ticagrelor
  • Pharmacologic Category: Antiplatelet agent
  • Dosage Forms: Tablet, Oral (60 mg ,90 mg )
  • Patients with acute coronary syndrome (ACS) or a history of myocardial infarction
  • Patients with coronary artery disease (CAD) at high risk for ischemic events
  • Patients with acute ischemic stroke (NIHSS ≤5) or high-risk transient ischemic attack (TIA)

About Ticalix:

Ticagrelor and its major metabolite reversibly interact with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.


Did you know . . . ???!

Do you know what is the rate of heart attack recurrency for patients who have survived from prior myocardial infarction?

Each 2.5 minutes, one heart attack occurred again for patients who have survived from prior myocardial infarction, Ticagrelor was entered to handle this situation and remarkably reduces the rate of death from cardiovascular events, myocardial infarction or stroke and recurrent cardiovascular events.


دی ان ان